Gilead (NASDAQ: GILD) director to sell 5,000 shares in 2026

Rhea-AI Filing Summary

GILEAD SCIENCES, INC. (GILD) has a notice of proposed sale of securities filed on behalf of director Jeffrey Bluestone under Rule 144. The notice covers the potential sale of 5,000 shares of Gilead common stock, expected on or about 08/20/2026, following an exercise of stock options for cash. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate value of $738,000.00, and are listed for trading on NASDAQ.

Key Figures

Shares proposed to be sold: 5,000 shares of common stock Aggregate market value: $738,000.00 Planned sale date: 08/20/2026 +2 more

5 metrics

Shares proposed to be sold 5,000 shares of common stock Maximum number of Gilead Sciences, Inc. shares in this Rule 144 notice

Aggregate market value $738,000.00 Value associated with the 5,000 Gilead Sciences, Inc. shares

Planned sale date 08/20/2026 Date indicated for exercise of stock options and proposed sale

Issuer SEC File Number 000-19731 SEC file number for Gilead Sciences, Inc.

CUSIP/identifier 1239955155 Identifier listed with the common stock in the securities information

Key Terms

Rule 144, Exercise of Stock Options, Form 144, aggregate value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Common | 08/20/2026 | Exercise of Stock Options | Issuer"

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

aggregate value financial

"Common | Morgan Stanley Smith Barney LLC ... | 5000 | 738000.00"

FAQ

What does the Form 144 filing report for GILD?

The filing reports a planned sale under Rule 144 by director Jeffrey Bluestone of up to 5,000 shares of Gilead Sciences, Inc. common stock, following an exercise of stock options for cash and expected to occur on or about 08/20/2026.

How many Gilead Sciences (GILD) shares are covered by this Form 144?

The notice covers up to 5,000 shares of Gilead Sciences, Inc. common stock to be sold for the account of director Jeffrey Bluestone in a transaction reported under Rule 144.

What is the aggregate value of the GILD shares in this Form 144?

The planned Rule 144 sale for Gilead Sciences, Inc. common stock lists an aggregate value of approximately $738,000.00 for the 5,000 shares indicated in the notice.

How will the GILD shares in this Form 144 be acquired for sale?

The 5,000 shares of Gilead Sciences, Inc. common stock are indicated as being acquired through an Exercise of Stock Options for cash on 08/20/2026 before being sold under Rule 144.

Which broker is handling the planned GILD share sale in this Form 144?

The planned Rule 144 sale of Gilead Sciences, Inc. common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

On which market are the GILD shares in this Form 144 listed?

The common stock of Gilead Sciences, Inc. covered by this Form 144 notice is listed for trading on NASDAQ, as indicated in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 04:36 PM Accepted by SEC EDGAR 08/20/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001771814
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	6505743000
Name of Person for Whose Account the Securities are To Be Sold	JEFFREY BLUESTONE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	738000.00	1239955155	08/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2026	Exercise of Stock Options	Issuer			5000	08/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeffrey Bluestone
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)